Skip to content
10-K

Annual Report

PEAK PHARMACEUTICALS, INC. RMHI

0001199835-22-000838

← back to feed
Filed
Dec 19, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Dec 16, 2022 78.36M sh
Operating Cash Flow FY 2022 · Sep 30, 2022 −$68.55K
Operating Cash Flow FY 2022 · Sep 30, 2021 −$14.26K
Stockholders Equity FY 2022 · Sep 30, 2022 −$491.15K
Stockholders Equity FY 2022 · Sep 30, 2020 −$250.1K
Total Liabilities FY 2022 · Sep 30, 2022 $621.5K
Total Liabilities FY 2022 · Sep 30, 2021 $587.34K
Total Assets FY 2022 · Sep 30, 2022 $130.35K
Total Assets FY 2022 · Sep 30, 2021 $261.15K
Net Income FY 2022 · Sep 30, 2022 −$164.97K
Net Income FY 2022 · Sep 30, 2021 −$76.09K
Operating Income FY 2022 · Sep 30, 2022 −$163.3K
Operating Income FY 2022 · Sep 30, 2021 −$68.72K